- More than 20 years of experience in the development of innovative drugs
- More than 10 clinical trials in the U.S. and Europe
- More than 1,000 participants in our clinical development programs
- More than 100 researchers in 80 centers located in more than 10 different countries
At Sylentis, we are committed to eye health care and we make cutting-edge science available to patients and their environment. That is why we are committed to the development and manufacture of innovative medicines that transform their daily lives and bring tangible improvements to their quality of life.
Clinical trials are an essential tool for analyzing how an investigational drug works, its efficacy, possible side effects and the patients it may benefit.
Our progress is due in large part to the hundreds of volunteers who participate in our clinical trials and who make possible the development of safe, effective and quality new medicines.
You can consult the clinical trials of which Sylentis is a sponsor HERE